The Nexus Between Periodontal Inflammation and Dysbiosis

Introduction

Pathology of Periodontitis - The Three Critical Questions

1. Initiation

2. Exacerbation

3. Resolution

• Resolution of inflammation
• Return of tissue homeostasis
• Re-establishment of a commensal plaque microbiome in homeostatic equilibrium with the host

The Theoretical Framework - Historical Evolution

Specific Plaque Hypothesis

Ecological Plaque Hypothesis (Marsh, 1994)

Keystone Pathogen Hypothesis (Hajishengallis et al., 2012)

The IMPEDE Model - The Proposed Unifying Framework

The IMPEDE Model - Stage-by-Stage

Mechanisms Linking Inflammation and Dysbiosis

A. How Inflammation Drives Dysbiosis

1. Pocket formation and the anaerobic niche: Excess inflammation causes soft tissue swelling creating an early pocket. As the pocket deepens, the local environment becomes increasingly anaerobic.
2. Nutrient enrichment of the sulcus: Chronic inflammation increases gingival crevicular fluid (GCF) flow - rich in plasma proteins, tissue breakdown products, hemin, and amino acids. This selects for anaerobic, gram-negative proteolytic bacteria that use hemin and essential amino acids as energy sources (including P. gingivalis, T. denticola).
3. Oxidative stress: Severe periodontitis is characterized by increased reactive oxygen species (oxidative stress) and exuberant cytokine production (IL-1β, IL-6, TNF-α, IL-17), further altering the microbial niche.
4. Altered virulence factor expression: Growth conditions provided by the inflammatory environment change the physiology, pathogenicity, and virulence factor expression of the entire polymicrobial community. Transcriptomic analyses of progressive disease showed virulence factors are upregulated in both pathogens AND health-associated commensals - a remarkable finding.
5. Changes in metabolomic profile: Dysbiosis involves multi-directional metabolic cross-talks between subgingival microorganisms and the host. Metabolites like cadaverine, hydrocinnamate, butyric acid, and polyamines serve as metabolic signatures of severe disease.

B. How Dysbiosis Drives Inflammation

1. The dysbiotic biofilm generates a sustained inflammatory response through continuous antigen presentation and PAMP-DAMP signaling.
2. Pathobionts such as P. gingivalis can subvert complement and Toll-like receptor signaling, creating a state of dysregulated rather than absent immunity - allowing pathogens to thrive while disabling protective responses.
3. A dysbiotic microbiome triggers Th17 cells to mediate oral mucosal immunopathology (Dutzan et al., 2018).
4. The feedforward loop: more dysbiosis → more tissue breakdown → more hemin/nutrients → more anaerobe growth → more dysbiosis.

The Role of Specialized Pro-Resolving Mediators (SPMs)

• Arachidonic acid → Lipoxins
• Omega-3 PUFAs (EPA) → Resolvins (E-series)
• Omega-3 PUFAs (DHA) → Resolvins (D-series), Protectins, Maresins

SPMs and the Microbiome - Key Experimental Evidence

• When used as a topical therapeutic in experimental periodontitis, RvE1 prevented and reversed disease and promoted bone remodeling.
• Critically, RvE1 caused the spontaneous disappearance of P. gingivalis WITHOUT mechanical or antimicrobial therapy.
• In rat experimental periodontitis (Lee et al., 2016), topical RvE1 induced significant regeneration of periodontal soft tissues and bone, and the inflammation-induced shifts in local microbiota were markedly rescued.

1. Local environmental conditions (driven by inflammation) impact the composition of the microbiota.
2. The impact of inflammation on the microbiome is modifiable.

Biogeography and Spatial Architecture of Dysbiosis

Site Specificity

• P. gingivalis and T. denticola are predominantly located in deep pockets (>4 mm depth).
• These pathogens form microcolony blooms in the biofilm surface layer adjacent to the epithelial lining at the base of deep pockets - precisely positioned to release outer membrane vesicles loaded with virulence factors into subjacent tissues.
• They also have access to the exudate from inflamed tissue (hemin, amino acids, growth factors from GCF).

Microbial Succession Model

• Pockets of 6 mm depth show higher diversity and species richness compared to pockets >7-8 mm.
• Very deep pockets are more homogeneous, with Bacteroidetes being the most abundant phylum (>50% of species from families of known/suspected periodontal pathogens).
• This pattern supports a model of microbial succession: disease-associated species initially invade/emerge in healthy microbiota creating a diverse transitional community, which is then temporally and spatially replaced by predominantly disease-associated species as pockets deepen.

The Dysbiotic Signature as a Biomarker

What Drives the Change - Inflammation or Bacteria? The Temporal Sequence

Clinical Implications

1. Debridement alone is insufficient for high-risk individuals, precisely because the underlying inflammatory drive remains. Host modulation is required alongside plaque control.
2. Controlling inflammation controls the microbiome: Anti-inflammatory therapy (especially SPM-based) can shift microbial composition back toward a health-compatible state.
3. Return of eubiosis after treatment is possible because commensal species are not eliminated during dysbiosis - they are merely repressed. Once the inflammatory environment is resolved and debridement is performed, the commensals can re-establish as the principal biofilm components.
4. The dysbiotic signature (levels of key pathogens + metabolomic markers) may be used as a prognostic biomarker for imminent attachment loss.
5. Host risk factors (genetics, diabetes, smoking, obesity) modulate susceptibility by amplifying the inflammatory response, thereby accelerating the dysbiotic shift.

Systemic Connections

• Gut: Inflammation (IBD, obesity, type 2 diabetes) causes gut dysbiosis; gut dysbiosis drives systemic inflammation.
• Sepsis: SPMs like Resolvin D2 are potent regulators of leukocytes and control microbial sepsis.
• Rheumatoid Arthritis: Microbial dysbiosis of the oral OR gut microbiome may predispose to RA development (Harrison's Principles of Internal Medicine, 22E).
• Preterm birth: Maternal periodontal disease is linked to increased risk, likely through shared variations in microbial states and inflammatory responses.
• Cardiovascular disease: Circulating microbiome differences have been documented in cardiovascular disease patients vs. healthy individuals.

Concluding Summary

1. Bacteria are the necessary cause of gingivitis, but it is the host inflammatory response that determines whether disease progresses.
2. Dysbiosis is clearly associated with periodontitis, but whether it initiates or is a consequence of disease has not been definitively settled - the weight of evidence favors dysbiosis as a consequence and exacerbator, not the primary initiator.
3. Inflammation and the resident microbiome are linked in a bidirectional balance in health and a bidirectional imbalance in disease - a feedforward loop.
4. The IMPEDE model proposes that inflammation is the principal driver, modulating the polymicrobial biofilm through the continuum of health (Stage 0) → gingivitis (I) → early periodontitis (II) → advancing periodontitis with dysbiosis (III) → late-stage opportunistic polymicrobial infection (IV).
5. SPMs represent the key regulatory mechanism linking inflammation resolution to microbiome restoration - offering a therapeutic target beyond traditional antimicrobial/debridement approaches.
6. The future of periodontitis management lies in harnessing this nexus: resolving inflammation to control dysbiosis, rather than simply eliminating bacteria to secondarily reduce inflammation.

The Nexus Between Periodontal Inflammation and Dysbiosis

Introduction

• What drives the shift from gingivitis to destructive periodontitis?
• When and how does the subgingival microbiome become dysbiotic?
• Is dysbiosis spontaneous or driven by the inflammatory environment?
• What is the temporal relationship between the dysbiotic microbiome and the innate/acquired immune response?
• Is bacterial tissue invasion an initiator or a consequence of disease?

Pathology of Periodontitis - The Three Critical Questions

1. Initiation

2. Exacerbation

3. Resolution

• Active resolution of inflammation
• Return of tissue homeostasis
• Re-establishment of a commensal plaque microbiome in homeostatic equilibrium with the host

Theoretical Framework - Historical Evolution of Models

Specific Plaque Hypothesis

Ecological Plaque Hypothesis (Marsh, 1994)

Keystone Pathogen Hypothesis (Hajishengallis et al., 2012)

The IMPEDE Model - The Proposed Unifying Framework

Stage-by-Stage Analysis of the IMPEDE Model

Stage 0 - Periodontal Health

Stage I - Gingivitis (Inflammation)

Stage II - Polymicrobial Emergence / Early Periodontitis

Stage III - Inflammation-Mediated Dysbiosis / Early Periodontitis

• Emergence and proliferation of specific pathobiont species
• A self-sustained feedforward loop of dysbiosis exacerbating inflammation and inflammation exacerbating dysbiosis
• Uncontrolled tissue destruction

Stage IV - Late Stage Periodontitis

IMPEDE Stages, Disease Classification, and Treatment

• Panel A shows the continuum from health (Stage 0) through advancing disease (Stages I-IV), with each stage defined by the degree of inflammation, polymicrobial diversity, and tissue destruction.
• Panel B makes the therapeutic implication explicit: without treatment, inflammation exacerbates from Stage 0 through Stage III; with inflammation resolution-focused periodontal treatment, the disease trajectory reverses, aiming to return to Stage 0. This is not merely plaque removal - it is resolving inflammation to restore microbial homeostasis.

Mechanisms Linking Inflammation and Dysbiosis

A. How Inflammation Drives Dysbiosis (Inflammation → Dysbiosis)

1. Pocket formation and the anaerobic niche: Excess inflammation causes soft tissue swelling, creating an early pocket. As the pocket deepens, the local environment becomes increasingly anaerobic - selectively favoring obligate anaerobes.
2. Nutrient enrichment via GCF: Chronic inflammation dramatically increases gingival crevicular fluid (GCF) flow. GCF is rich in plasma proteins, tissue breakdown products, hemin, amino acids, and essential growth factors - providing ideal nutrients for anaerobic gram-negative proteolytic bacteria (P. gingivalis uses hemin as its primary iron and energy source).
3. Oxidative stress and cytokine milieu: Severe periodontitis involves increased reactive oxygen species and exuberant cytokine production (IL-1β, IL-6, TNF-α, IL-17), further altering the microbial niche and selecting for oxidative-stress-tolerant species.
4. Upregulation of virulence factors: Growth conditions in the inflammatory environment change the physiology, pathogenicity, and virulence factor expression of the entire polymicrobial community. Transcriptomic analyses of progressive disease (metatranscriptomics) revealed that virulence factors are upregulated in both pathogens AND health-associated commensals - a fundamentally important finding.
5. Metabolomic shifts: Dysbiosis involves multi-directional metabolic cross-talk between subgingival organisms and the host. Metabolites including cadaverine, hydrocinnamate, butyric acid, polyamines, and products of arginine/proline/lysine metabolism serve as signatures of severe disease.

B. How Dysbiosis Drives Inflammation (Dysbiosis → Inflammation)

1. The dysbiotic biofilm generates sustained inflammation through continuous antigen presentation and PAMP/DAMP signaling.
2. Pathobionts such as P. gingivalis subvert complement and Toll-like receptor signaling, creating dysregulated (rather than absent) immunity - allowing pathogens to thrive while disabling protective responses.
3. A dysbiotic microbiome triggers Th17 cells to mediate oral mucosal immunopathology in both mice and humans (Dutzan et al., 2018).
4. The feedforward loop: more dysbiosis → more tissue breakdown → more hemin/nutrients → more anaerobic pathogen growth → more dysbiosis.

The Role of Specialized Pro-Resolving Mediators (SPMs)

RvE1 and Dysbiosis - Key Experimental Evidence

• Used as a topical therapeutic in rat experimental periodontitis, RvE1 prevented and reversed disease and promoted bone remodeling.
• Critically, RvE1 caused the spontaneous disappearance of P. gingivalis WITHOUT mechanical or antimicrobial therapy.
• Topical RvE1 induced regeneration of periodontal soft tissues and bone, and the inflammation-induced shifts in local microbiota were markedly rescued (Lee et al., 2016).

1. Local environmental conditions (driven by inflammation) impact the composition of the microbiota.
2. The impact of inflammation on the microbiome is modifiable through resolution pathways.

Biogeography and Spatial Architecture of Dysbiosis

Site Specificity

• Oral microbes are site/niche specialists - the fine-scale positioning of a pathogen within a polymicrobial infection site can greatly alter its virulence potential.
• P. gingivalis and T. denticola are predominantly located in deep pockets (>4 mm depth).
• These pathogens form microcolony blooms in the biofilm surface layer adjacent to the epithelial lining at the base of deep pockets - optimally positioned to release outer membrane vesicles loaded with virulence factors into subjacent tissues, and to access the exudate from inflamed tissue (hemin, amino acids, GCF growth factors).

Microbial Succession Model

• Pockets of 6 mm depth: higher diversity and species richness
• Pockets >7-8 mm: more homogeneous communities, Bacteroidetes dominant (>50% from families of known/suspected pathogens)
• This supports a microbial succession model: disease-associated species initially invade/emerge in healthy microbiota creating a diverse transitional community (Stage II-III), then this transitional dysbiotic microbiota is temporally and spatially replaced by predominantly disease-associated species as pockets deepen (Stage IV).

The Dysbiotic Signature as Biomarker

What Comes First? - Evidence for Temporal Primacy of Inflammation

Resolution of Disease and Return of Eubiosis

• Commensals can re-establish as the principal biofilm components.
• Interspecies competition among commensals (which is antagonistic to gram-negative pathogens) can resume.
• Oral homeostasis (eubiosis) can return to a treated site.

Clinical Implications

1. Debridement alone is insufficient for high-risk individuals because the underlying inflammatory drive remains. Host modulation alongside plaque control is required.
2. Controlling inflammation controls the microbiome: Anti-inflammatory/pro-resolving therapy (especially SPM-based approaches) can shift microbial composition back toward a health-compatible state.
3. Targeting resolution, not just suppression: NSAIDs fail to reverse dysbiosis; SPMs succeed. This has profound implications for how we design adjunctive pharmacotherapy for periodontitis.
4. Systemic inflammatory burden: Conditions such as type 2 diabetes, obesity, and cardiovascular disease amplify the inflammatory drive, accelerating the dysbiotic shift and worsening periodontal outcomes. Conversely, periodontal treatment that resolves inflammation may have systemic benefits.
5. Dysbiotic signature as a prognostic tool: Monitoring microbial composition and metabolomic profiles at individual sites may help predict impending disease activity before clinical signs worsen.

Systemic Connections

• Gut/IBD: Inflammation causes gut dysbiosis; gut dysbiosis drives systemic inflammation (Kamada et al., 2013; Zeng et al., 2017).
• Type 2 Diabetes/Obesity: Systemic upregulation of inflammation causes gut microbiome dysbiosis; periodontal dysbiosis worsens glycemic control.
• Rheumatoid Arthritis: Microbial dysbiosis of the oral OR gut microbiome may predispose to RA development.
• Preterm birth: Maternal periodontal disease is linked to increased preterm birth risk, likely through shared variations in microbial states and inflammatory responses.
• Sepsis: SPMs (e.g., Resolvin D2) are potent regulators of leukocytes in microbial sepsis - showing that pro-resolving pathways are systemically relevant.

Concluding Summary

1. Bacteria are the necessary cause of gingivitis, but it is the host inflammatory response that determines whether disease progresses to destructive periodontitis.
2. Dysbiosis is clearly associated with periodontitis, but current evidence supports it as a consequence and exacerbator, not the primary initiator of disease.
3. The IMPEDE model (Figure 1) proposes inflammation as the principal driver, progressing through health (Stage 0) → gingivitis (I) → early periodontitis with polymicrobial emergence (II) → inflammation-mediated dysbiosis (III) → late-stage opportunistic polymicrobial infection (IV).
4. Inflammation and the resident microbiome are linked in a bidirectional balance in health and a bidirectional imbalance in disease - a self-sustained feedforward loop that is the heart of the pathogenesis.
5. SPMs are the key regulatory mechanism linking inflammation resolution to microbiome restoration, offering therapeutic targets that go far beyond traditional debridement and antimicrobial approaches.
6. Figure 2B captures the therapeutic imperative: with inflammation resolution-focused periodontal treatment, the disease trajectory can be reversed from advancing disease back to Stage 0 health - by resolving inflammation to control dysbiosis, rather than solely eliminating bacteria to secondarily reduce inflammation.